back to overview

news blog

Digital healthcare: patient-first?

April 15, 2021 + Jessica Di Palo
4 Min read

We have been collaborating with, a data provider on startups, growth companies and tech ecosystems around the globe and INKEF Capital, a venture capital firm based in Amsterdam on our "Digital Healthcare Report". Today we are happy to present our results.

Digital Healthcare patient First? Healthtech Report

After a year where healthcare has been in the spotlight, European healthtech and digital healthcare startups are now worth a combined $41B, according to a new report us,, and INKEF Capital, up from $8B in 2015. 

It’s been said that Covid-19 brought “10 years of market evolution in 10 weeks” within healthcare and technology adoption, but according to this new report, the biggest changes are still yet to come in the next two years and beyond. 

Spending more for less

Global healthcare expenditure is now around $8 trillion, of which $2 trillion is spent in Europe and $3.5 trillion in the US. Ballooning healthcare costs are putting a strain on government finances, but also on the outcomes of patients.

Patients increasingly receive lesser outcomes, at higher direct (out-of-pocket, insurance) and indirect (tax, co-payments) costs. 

An ageing population, chronic diseases, obesity, and rising costs of drugs, met by a complex market that has been slow to adopt technology, means there are potentially huge savings to be made in the largest consumer category. VCs are certainly betting on Healthcare being the next big digital frontier.

5x in 5 years

Europe’s healthtech companies are now worth a combined $41B, up from $8B in 2015. Drug discovery, telehealth and online pharmacy startups have so far accrued the most value in European healthtech.

A herd of digital healthcare unicorns

So far some of the world’s most successful startups have emerged in markets where consumers direct relatively low amounts of their spending. Healthcare by comparison is one of the largest consumer categories, yet remains largely undigitized at almost every level of the value chain and patient journey.

Europe is already starting to see big Healthtech companies emerge in telehealth (Babylon, Kry), operations software (Doctolib, Docplanner) and insurance (wefox). And any market in the trillions could certainly support a European multi-decacorn.

The future of healthcare

Of course the pandemic has had a drastic effect on healthcare and healthtech, in particular accelerating the adoption, demand and trust for telehealth and other patient-interface level solutions. But there are broader industry digitization shifts that will have a bigger impact still on our collective healthcare.

Political and regulatory innovation, combined with technological advances can enable improved outcomes and cost-efficiency in healthcare, well beyond the pandemic. Our healthcare is set to become more proactive, looking to prevent illness or catch and diagnose ailments earlier. We’ll be empowered through personalised, decentralized care, with more power being put in the patient’s hands along the patient’s journey. And outcomes will become a focus of spending. Digital solutions can enable evidence-based outcomes and drive value-based spending.

Healthcare may have been slow to adopt digitization, but its impact here has the potential to be more meaningful than anywhere else. Digitalization will literally save lives.

Learn more about our portfolio companies mentioned in this digital healthcare report

About is the foremost data provider on startups, growth companies and tech ecosystems in Europe and around the globe. Founded in Amsterdam in 2013, now works with many of the world’s most prominent investors, entrepreneurs and government organizations to provide transparency, analysis and insights on startups and venture capital activity.

About MTIP 

MTIP is a fast-growing pan-European healthtech growth capital investor, based in Basel Switzerland. We invest in digital health and digitally connected medical device companies, with offerings that provide clear health-related economic benefits. Our entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with our portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors.

Share the Article


MTIP invests in Mediktor

New investment in Mediktor


SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right


MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round


MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia


Private Equity 101: Part one – Glossary

Are you new to the healthtech space?


Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey


Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations


MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II


How to pitch to a healthtech Investor

Blog Pitching


MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health


MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020


4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour


MTIP invests in Trialbee

New investment in Trialbee


TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round


The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April


MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020


New MTIP investment in Oviva

New investment in Oviva


Whitepaper: A positive prognosis for the future of healthtech

Our first Whitepaper


Elite Summit 2019 – Interview with our Managing Partner Christoph Kausch

Elite Summit 2019


MTIP Healthcare Clinic 2019

Healthcare clinic 2019

New MTIP investment in Cynerio

New investment in Cynerio


MTIP invests in Lumeon Ltd.

New investment in Lumeon

Magenverkleinerung mit der Handnähmaschine

Nitinotes news paper article